Pharmacological characterization and positron emission tomography evaluation of 4-[76Br]bromodexetimide and 4-[76Br]bromolevetimide for investigations of central muscarinic cholinergic receptors

Nuclear Medicine and Biology

Volumn 23, Issue 3, 1996, Pages 235-243

  Loc'h, C ^a,b   Kassiou, M ^c   Strijckmans, V ^a   Bottlaender, M ^b   Katsifis, A ^c   Schmid, L ^b   Maziere M ^b   Lambrecht, R M ^c   Maziere B ^a  

^a DIF   (France)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^c AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Bromine 76; Dexetimide; Levetimide; Muscarinic cholinergic receptors; Positron emission tomography; Radiotracers

Indexed keywords

4 BROMODEXETIMIDE; 4 BROMOLEVETIMIDE; ATROPINE; BROMINE 76; DEXETIMIDE; LEVETIMIDE; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; RAT;

ANIMALS; AUTORADIOGRAPHY; BRAIN; BROMINE RADIOISOTOPES; CELL MEMBRANE; CEREBRAL CORTEX; DEXETIMIDE; FRONTAL LOBE; ISOTOPE LABELING; KINETICS; MALE; MUSCARINIC ANTAGONISTS; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029948218     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02052-7     Document Type: Article

References (41)

1. Albanus L. (1970) Central and peripheral effects of anticholinergic compounds. Acta Pharmacol. Toxicol. 28, 305-326.
2. Bartus R. T., Dean R. L., Beer B. and Lippu A. S. (1987) Cholinergic psychopharmacology: an integration of human and animal research on memory. In Psychopharmacology: The Third Generation of Progress (Edited by Meltzer H. Y.), pp. 211-218. Raven Press, New York.
3. Bonner T. L., Buckley N. J., Young A. C. and Brann M. R. (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237, 527-532.
4. Buckley N. F., Bonner T. I., Buckley C. M. and Brann M. R. (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHOK1 cells. Mol. Pharmacol. 35, 469-476.
5. Cortes R., Probst A. and Palacios J. M. (1987) Quantitative light microscopic autradiographic localization of cholinergic muscarinic receptors in the human brain: forebram. Neurosciences 20, 65-107.
6. 11C]levetimide. Appl. Rad. Isot. 39, 291-295.
7. 11C-methyl]-benztropine. Synapse 5, 213-227.
8. Frey K. A. and Howland M. H. (1992) Quantitative autoradiography of muscarinic cholinergic receptor binding in the rat brain: distinction of receptor subtypes in antagonist competition assays. J. Pharmacol. Exp. Therap. 263, 1391-1400.
9. Hill A. W. (1910) The possible effects of the aggregation of the molecules of hemoglobin on its dissociation curves. J. Physiol. 40, 4-7.
10. 18F]-Fluorodexetimide. Syntheses and biodistribution. Nucl. Med. Biol. 18, 247-252.
11. 76Br]-4-Bromolevetimide: radiotracers for studying muscarinic cholinergic receptors using PET. J. Lab. Comp. Radiopharm. 36, 259-266.
12. 3H]-dexetimide. J. Neurochem. 33, 1223-1227.
13. 76Br]MBBG). Nucl. Med. Biol. 21, 49-55.
14. Lowry O. H., Rosebrough N. J. and Farr AL (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
15. 125I]iododexetimide binding to muscarinic cholinergic receptors in the rat heart. J. Nucl. Med. 32, 76-80.
16. 76Br]bromolisuride. In Neuropharmacology (Edited by Bunney W. E., Hippius A., Laakmann G. and Schmaub B. M.), pp. 409-417. Springer-Verlag, New York.
17. 11C]-methiodide quinuclidimyl benzylate a muscarinic antagonist for in vivo studies of myocardial muscarinic receptors. J. Radioanal. Chem. 76, 305-309.
18. 11C]-formaldehyde. Appl. Radiat. Isot. 39, 373-379.
19. 11C]NMPB) in the rat (abstract). J. Nucl. Med. 29, 768.
20. Mulholland G. K., Otto D. M., Jewett D. M., Kilbourn M. R., Koeppe R. A., Sherman P. S., Petry N. A., Carey J. E., Atkinson E. R., Archer S., Frey K. E. and Kuhl D. E. (1992) Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2α-tropanyl benzylate: a central muscarinic receptor imaging agent. J. Nucl. Med. 33, 423-430.
21. 123I]iododexetimide and single photon emission computed tomography. Ann. Neurol. 34, 235-238.
22. 123I]-4-iodolevetimide. J. Cereb. Blood Flow Metab. 12, 562-570.
23. Nicoll R. A., Malenka R. C. and Kauer J. A. (1990) Functional comparison of neurotransmitter subtypes in mammalian central nervous system. Physiol. Rev. 70, 513-565.
24. Pauly J. R., Stitzel J. A., Marks M. J. and Collins A. C. (1989) An autoradiographic analysis of cholinergic receptors in mouse brain. Brain Res. Bull. 22, 453-459.
25. Peralta E. G., Ashkenazi A., Winslow J. W., Ramachandran J. and Capon D. J. (1988) Differential regulation of PI hydrolysis and adenyl cyclase by muscarinic receptor subtypes. Nature 334, 434-437.
26. 11C]-3-Quinuclinidylbenzylate (QNB). J. Lab. Comp. Radiopharm. 27, 1257-1265.
27. Ramachandran J., Peralta E. G., Askhenazi A., Winslow A., Winslow J. W., Smith D. H. and Capon D. J. (1989) Structural and functional diversity of muscarinic acetylcholine receptor subtypes. Prog. Clin. Biol. Res. 289, 327-329.
28. Reinikainen N.J., Reinikamen P. J., Halonen T. and Laasko M. (1987) Decreased muscarinic receptors binding in cerebral cortex and hippocampus in Alzheimer's disease. Life Sci. 41, 453-461.
29. Riche D., Hantraye P., Guibert B., Naquet R., Loc'h C., Mazière M. (1988) Anatomical atlas of baboon's brain in the orbito-meatal plane used in positron emission tomography. Brain Res. Bull. 20, 283-301.
30. Rinne J. O., Looberg P., Marjamaki P. and Rinne U. K. (1989) Brain muscarinic receptor subtypes are differently affected in Alzeimer's disease and Parkinson's disease. Brain Res. 483, 402-406.
31. Rugberg M., Ploska A., Javoy-Agid F. and Agid Y. (1982) Muscarinic binding and acetycholine transferase activity in Parkinsonian subjects with reference to dementia. Brain Res. 232, 129-139.
32. 125I]-4-iodolevetimide. Neuropharmacol. 32, 1441-1443.
33. Scatchard G. (1949) The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51, 660-672.
34. 125I]-dexetimide to central and myocardial muscarinic receptors. Eur. J. Nucl. Med. 18, 447-452.
35. 11C]-quinuclidinyl benzylate and positron emission tomography in baboons. Eur. J. Pharmacol. 213, 275-284.
36. 11C]-Scopolamine: synthesis and distribution in rat brain. J. Lab. Comp. Radiopharm. 20, 1229-1236.
37. Wastek G. J., Stern L. Z., Johnson P. C. and Yamamura H. I. (1976) Huntington's disease: regional alteration in muscarinic cholinergic receptor binding in human brain. Life Sci. 19, 1033-1040.
38. Weiland G. A. and Molinoff P. B. ( 1981 ) Quantitative analysis of drug receptor interactions: i. Determination of kinetic and equilibrium properties. Life Sci. 29, 313-330.
39. 123I]-4-Iododexetimide, a potent muscarinic cholinergic receptor antagonist. J. Med. Chem. 32, 1057-1062.
40. 18F]Fluorodexetimides. J. Lab. Comp. Radiopharm. 28, 1189-1199.
41. 18F]-fluorodexetimide. Life Sci. 48, 1385-1394.